Browsing: Review
OPEC is set to hold its Joint OPEC/non-OPEC Ministerial Monitoring Committee (JMMC) meeting today to review current market conditions. No…
travellinglight/iStock via Getty ImagesBiogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) are expected to face another delay in launching their new Alzheimer’s drug,…
scanrail/iStock via Getty ImagesCalumet (NASDAQ:CLMT) said late Tuesday it must wait to receive the first part of its previously approved…
Magdalena WygralakGSK (NYSE:GSK) announced Tuesday that the EU drug regulator has agreed to review depemokimab, an experimental monoclonal antibody targeting…
High risk warning: Foreign exchange trading carries a high level of risk that may not be suitable for all investors.…
Sundry PhotographyThe FDA has accepted Merck’s (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known…
The surge in cryptocurrency ETFs has expanded beyond Bitcoin and Ethereum, with a diverse range of digital assets like Dogecoin,…
Jacques LOIC X4 Pharmaceuticals (NASDAQ:XFOR) announced Friday that the EU regulators agreed to review its marketing authorization application for mavorixafor,…
The government has launched its promised independent review into the loan charge but has been met with criticism from campaigners…
Professor25 The U.S. FDA has granted priority review to Verastem Oncology’s (NASDAQ:VSTM) combination of avutometinib and defactinib for a type…